Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Axonics, Inc. (AXNX) comes out victorious in a patent trial against Medtronic (MDT), as the jury rules in its favor, awarding ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

Axonics founder and CEO Raymond Cohen accepts a Business Journal Innovator of the Year award during a Sept. 12 ceremony.

Axonics Inc. (NASDAQ:AXNX) rose 1.5% in after hours trading after a jury voted in its favor in a patent dispute with Medtronic (MDT). Medtronic (MDT) was seeking $150 million in a patent dispute ...

On Friday, Axonics Inc (AXNX) stock saw a decline, ending the day at $69.15 which represents a decrease of $-0.10 or -0.14% from the prior close of $69.25. The stock opened at $69.26 and touched a low ...

IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX) today announced that the jury has returned a unanimous verdict in the patent infringement lawsuit brought by Medtronic against Axonics ...